Informationen på denna sida är avsedd för journalister, press och media.Klicka ja för att komma till nyhetsrummet. Klickar du nej kommer du tillbaka till mynewsdesk.com.
The gender health gap is real. Women have higher rates of sick leave than men, are more affected by mental illness, and have been historically underrepresented in medical research.This gender health gap must be reduced and completely eradicated. To address this societal problem and generate concrete solutions to solve it, Sahlgrenska Science Park, GoCo Health Innovation City, AstraZeneca, and
The HealthTech Award 2024 is now accepting entries! This prestigious award, a celebration of healthtech innovations that significantly impact people's lives, invites companies from the Nordics and Baltics to participate.Organized by GREAT, Vitalis and Sahlgrenska Science Park’s CO-AX accelerator, this 4th edition recognizes pioneering companies that have developed healthtech solutions demonstr
Building on its legacy of fostering impactful healthtech innovations, the CO-AX accelerator at Sahlgrenska Science Park opens its doors for the spring 2024 batch of entrepreneurial talent. This call is directed towards innovators and startups who are leveraging technology to address global health challenges.
CO-AX, the healthtech accelerator at Sahlgrenska Science Park, proudly acknowledges the recent achievements of VERIGRAFT, a prominent member of its life science community. VERIGRAFT has reached a major regulatory safety milestone in the TECVI-1 trial, further supported by extended funding from Vinnova CAMP for their arterial graft development project.TECVI-1 trial: a major step forwardThe
Konvoj, den AI-drivna schemaoptimeringsplattformen som revolutionerar personalplaneringen inom vården, har tillsammans med samarbetspartnern North Link blivit beviljade 2 miljoner kronor i bidrag från Sveriges innovationsmyndighet Vinnova. Bidraget är en del av Vinnovas satsning för att stärka jämställdhetsaspekter inom den digitala teknikutvecklingen.
CO-AX, the healthtech accelerator at Sahlgrenska Science Park, is excited to announce the appointment of Siddhartha Khandelwal, PhD, as its new Deal Flow and Growth Manager. Siddhartha's role at CO-AX will be pivotal in attracting an increased influx of high-impact entrepreneurs and early-stage companies focused on global health challenges.
The CO-AX accelerator at Sahlgrenska Science Park welcomes five new visionaryhealth companies. The selected companies: ANYO Labs, Beat Vascular Health, Biotech Fluidics, Holtra and LUE Medtech, will benefit from CO-AX's customized programs to accelerate their growth and propel their paths to market. Membership in CO-AX provides the companies with invaluable tools, resources and connections.
Sahlgrenska Science Park is pleased to announce that Cecilia Edebo has been appointed as CEO. Starting early next year, Cecilia’s mission will be to further develop Sahlgrenska Science Park as a leading catalyser of collaborative health innovation.
När du väljer att skapa ett konto och följa ett nyhetsrum kommer dina personuppgifter behandlas av oss och av ägaren av nyhetsrummet för att du ska kunna motta nyheter och uppdateringar enligt dina bevakningsinställningar.
För att läsa mer om detta, var vänlig läs vår Integritetspolicy som berör vår behandling av dina personuppgifter, och Integritetspolicy för Contacts som berör behandlingen av dina personuppgifter från ägaren av nyhetsrummet du följer.
Vänligen notera att våra Användarvillkor gäller alla våra tjänster.
Du kan dra tillbaka ditt samtycke när som helst genom att avregistrera dig eller genom att ta bort ditt konto.
Mejl skickat till __email__. Klicka på länken i mejlet för att följa Sahlgrenska Science Park.
